NCT05251389 - Fecal Microbiota Transplantation (FMT) (from ICI non-responder) vs Fecal Microbiota Transplantation (FMT) (from ICI responder) & Melanoma (cutaneous)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Study overview

It is a randomized clinical phase I/II treatment trial studying Fecal Microbiota Transplantation (FMT) (from ICI non-responder) vs Fecal Microbiota Transplantation (FMT) (from ICI responder) in patients with advanced (stage III or IV) Melanoma (cutaneous)

Primary outcome measures

Clinical benefit (stable disease (SD), partial response (PR), complete response (CR)

Results

No published results were found as of May 2026

…

AI Chat

11/5/2026

Chat with our artificial intelligence:

Start chat!